WGS

GeneDx Holdings Corp

61.88

+1.34+2.21%

Pre Market: 60.61 -1.27 -2.05%05:50 07/29 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE60.52/60.54

TODAY RANGE59.05-65.77

VOL26

MARKET CAP1.84B

52 WEEK RANGE32.21-170.87

AVG VOL (3M)1.35M

% TURNOVER2.41%

TURNOVER0

P/E (TTM)-23.1908

% RANGE11.10%

EPS(TTM)-2.6683

P/E(FORWARD)-17.6046

P/B7.22

BVPS8.57

DIVIDEND--

P/S4.233

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP1.61B

SHARES OUTSTANDING29.69M

NEXT EARNINGS07/27-07/31

FREE FLOAT26.04M

LOT SIZE1

EX-DATE05/04/2023

News

Press Releases

Financial Reports

Profile

TipRanks·5d ago
BTIG Sticks to Its Buy Rating for GeneDx Holdings (WGS)
Seeking Alpha·6d ago
Exagen: A Small Diagnostics Company Approaching An Inflection Point
PR Newswire·6d ago
WGS DEADLINE ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- August 3, 2026 Deadline
PR Newswire·6d ago
WGS Deadline: WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit
PR Newswire·6d ago
WGS Deadline Alert: Levi & Korsinsky Reminds GeneDx Holdings Corp. (WGS) Investors of Securities Class Action Deadline on August 3, 2026
PR Newswire·07/21 20:02
WGS INVESTOR DEADLINE: GeneDx Holdings Investors with Substantial Losses Have Opportunity to Lead the GeneDx Class Action Lawsuit- Hagens Berman
Seeking Alpha·07/19 14:53
Thrivent Small Cap Growth Fund Q2 2026 Portfolio Review
PR Newswire·07/18 14:59
GeneDx Holdings Corp. (WGS) Investors: August 3, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
PR Newswire·07/18 02:39
WGS Deadline: WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit
PR Newswire·07/18 02:00
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Dow Jones·07/16 22:02
Press Release: GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026
PUBT·07/16 20:06
GeneDx to report Q2 2026 results after market close, host conference call
PR Newswire·07/16 14:09
WGS DEADLINE: SueWallSt Reminds GeneDx Holdings Corp. Investors of Upcoming Securities Class Action Deadline
PR Newswire·07/15 23:55
WGS DEADLINE ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - August 3, 2026 Deadline
Reuters·07/15 10:19
GENEDX HOLDINGS CORP <WGS.O>: TD COWEN RAISES TARGET PRICE TO $85 FROM $55

Same Industry

Name/Symbol

Change%

Price

WGS

Hca Healthcare Inc

HCA

+1.94%

389.62

CHE

LH-WI

Univ Health Svc

UHS

+2.96%

155.75

Labcorp Holdings Inc

+1.98%

296.77

AMN

Quest Diagnostics Inc

DGX

-0.02%

227.86

Davita Inc

DVA

+0.50%

235.44

Tenet Healthcare Corp

THC

+17.17%

233.20

Ensign Group Inc

ENSG

+3.27%

172.99

CRVL

Addus Homecare Corp

ADUS

+2.35%

114.55

Cvs Health Corp

CVS

+2.07%

109.29

Acadia Healthcar

ACHC

+1.47%

34.51

EHC

EHC-WI

U S Physical Therapy

USPH

+2.21%

74.58

Ensign Group Inc

ENSGV

0.00%

Premier

PINC

0.00%

28.26

Select Medical

SEM

0.00%

16.51

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.